Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Huhn

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Medical Care|February 6, 2018
Serious About the Opioid Epidemic? Expand MedicaidAndrew S Huhn
Krankenpflege (Frankfurt Am Main, Germany)|November 1, 1991
[Characteristics of the various degrees in the quality of geriatric nursing--group living and group nursing]S Huhn, K Kämmer
Expert Opinion on Pharmacotherapy|December 22, 2025
Do we need to improve pharmacological approaches to treat insomnia in patients with opioid use disorder?David Wolinsky, Andrew S Huhn
Experimental and Clinical Psychopharmacology|July 15, 2021
Promoting harm reduction as a treatment outcome in substance use disordersAndrew S Huhn, Cassandra D Gipson
Journal of Substance Abuse Treatment|May 31, 2017
Why aren't physicians prescribing more buprenorphine?Andrew S Huhn, Kelly E Dunn
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 26, 2023
The orexin neurotransmitter system as a target for medication development for opioid use disorderA S Huhn, K E Dunn
Experimental and Clinical Psychopharmacology|June 10, 2021
Sleep disturbance as a therapeutic target to improve opioid use disorder treatmentAndrew S Huhn, Patrick H Finan
Brain and Behavior|September 23, 2021
Comprehensive pain management as a frontline treatment to address the opioid crisisJoseph Gregory Hobelmann, Andrew S Huhn
Addiction (Abingdon, England)|March 30, 2022
Commentary on Zolopa et al.: Trauma as an impediment to successful aging and a precipitant of opioid and stimulant use among older adultsAndrew S Huhn, Jennifer D Ellis
Current Psychiatry Reports|October 31, 2020
Challenges for Women Entering Treatment for Opioid Use DisorderAndrew S Huhn, Kelly E Dunn
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Medical Care|February 6, 2018
Serious About the Opioid Epidemic? Expand MedicaidAndrew S Huhn
Krankenpflege (Frankfurt Am Main, Germany)|November 1, 1991
[Characteristics of the various degrees in the quality of geriatric nursing--group living and group nursing]S Huhn, K Kämmer
Expert Opinion on Pharmacotherapy|December 22, 2025
Do we need to improve pharmacological approaches to treat insomnia in patients with opioid use disorder?David Wolinsky, Andrew S Huhn
Experimental and Clinical Psychopharmacology|July 15, 2021
Promoting harm reduction as a treatment outcome in substance use disordersAndrew S Huhn, Cassandra D Gipson
Journal of Substance Abuse Treatment|May 31, 2017
Why aren't physicians prescribing more buprenorphine?Andrew S Huhn, Kelly E Dunn
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 26, 2023
The orexin neurotransmitter system as a target for medication development for opioid use disorderA S Huhn, K E Dunn
Experimental and Clinical Psychopharmacology|June 10, 2021
Sleep disturbance as a therapeutic target to improve opioid use disorder treatmentAndrew S Huhn, Patrick H Finan
Brain and Behavior|September 23, 2021
Comprehensive pain management as a frontline treatment to address the opioid crisisJoseph Gregory Hobelmann, Andrew S Huhn
Addiction (Abingdon, England)|March 30, 2022
Commentary on Zolopa et al.: Trauma as an impediment to successful aging and a precipitant of opioid and stimulant use among older adultsAndrew S Huhn, Jennifer D Ellis
Current Psychiatry Reports|October 31, 2020
Challenges for Women Entering Treatment for Opioid Use DisorderAndrew S Huhn, Kelly E Dunn
Pageof 14